News und Analysen

Lucid Diagnostics (NASDAQ:LUCD), a diagnostics company focused on non-invasive detection of esophageal precancer and cancer, released its second quarter 2025 earnings results on August 13, 2025

Sbc Medical Group (NASDAQ:SBC), a provider of cosmetic and medical services with a broad franchise and technology platform, released its earnings for the second quarter of fiscal 2025 on August 13

Sanara MedTech (NASDAQ:SMTI), a developer of surgical wound care products and value-based care technology, reported its Q2 FY2025 earnings on August 13, 2025. The report showed the company’s GAAP

PDS Biotechnology (NASDAQ:PDSB), a clinical-stage immunotherapy company focused on innovative oncology and infectious disease solutions, released its second quarter results on August 13, 2025, for

Retail stocks have been through a few tough years. The SPDR S&P Retail ETF (NYSEMKT: XRT) posted a total return of 12% over the last year, far behind the S&P 500 (SNPINDEX: ^GSPC) index's 19%

Performance Food Group (NYSE:PFGC), a leading foodservice distributor serving restaurants, convenience stores, vending, and more, reported financial results for Q4 FY2025 on August 13, 2025. The

Instil Bio (NASDAQ:TIL), a clinical-stage biotechnology company focused on developing immunotherapies for cancer, released its second quarter 2025 earnings on August 13, 2025. The report highlighted

Perspective Therapeutics (NYSEMKT:CATX), a clinical-stage company focused on targeted radiopharmaceutical cancer therapies, reported results for Q2 2025 on August 13, 2025. The company posted GAAP

Cameco's (NYSE: CCJ) management styles the company as a "pure-play investment in the growing demand for nuclear energy," and with good reason. Its mix of uranium mining, nuclear fuel services, and

M-tron Industries (NYSEMKT:MPTI), a designer and manufacturer of frequency and spectrum control products for aerospace, defense, and high-reliability markets, released its earnings on August 12

Cava Group (NYSE:CAVA), a fast-casual restaurant operator focused on Mediterranean cuisine, released its results on August 12, 2025. The most significant news was a slowdown in same restaurant sales

Durect (NASDAQ:DRRX), a biopharmaceutical company focused on liver disease therapeutics, released results for the second quarter of fiscal 2025 on August 12, 2025. Durect posted better-than-expected

Tecogen (NYSEMKT:TGEN), a maker of distributed generation and specialized cooling solutions, reported its Q2 2025 results on August 12, 2025. The company posted revenue growth of 54.3%

Lyra Therapeutics (NASDAQ:LYRA), a clinical-stage biotechnology company focused on chronic rhinosinusitis (CRS) treatments, reported its second quarter 2025 results on August 12, 2025. The most

Iridex (NASDAQ:IRIX), a medical device company specializing in laser-based systems for eye disease treatments, reported its second quarter results on August 12, 2025, covering the three months ended

Webtoon Entertainment (NASDAQ:WBTN), a global digital comics publisher and platform operator, reported results on August 12, 2025. Revenue (GAAP) reached $348.3 million, coming in $7.7 million above

Vicarious Surgical (NYSE:RBOT), a developer focused on next-generation robotic technology for minimally invasive surgery, released its second quarter 2025 financial results on August 12, 2025. The

Verrica Pharmaceuticals (NASDAQ:VRCA), a specialty dermatology company focused on skin disease treatments, released its earnings for the second quarter of fiscal 2025 on August 12, 2025. The

Luminar Technologies (NASDAQ:LAZR), a leading developer of laser-based sensors and software for advanced driver-assistance systems and autonomous vehicles, reported results for Q2 2025 on August 12

Nexgel (NASDAQ:NXGL), a maker of hydrogel-based wound care and beauty products, released its second quarter results for fiscal 2025 on August 12, 2025. The key news from the release was strong

Fractyl Health (NASDAQ:GUTS), a clinical-stage biotech developing interventions for obesity and Type 2 Diabetes (T2D), reported its second quarter 2025 results on August 12, 2025. The period was

Cameco's (NYSE: CCJ) share price has roughly doubled in value over the past year. Much of that gain has taken place since a rally started in April. Can Cameco's shares continue to rocket higher, or

CXApp(NASDAQ:CXAI) reported fiscal Q2 2025 (period ended June 30, 2025) earnings on August 11, 2025, highlighting flat revenue of $1.22 million, gross margin improved to 86%, and significant

The name Occidental Petroleum (NYSE: OXY) gets more attention than it used to, thanks to the involvement of Warren Buffett and Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), the company Buffett

Crude oil prices have declined this year. Brent, the global benchmark, has fallen by more than 15%, dropping from the low $80s to the mid-$60s. This decline hurt the cash flows of most oil